Drug profile · INN
naloxegol
MOVENTIG
naloxegol (MOVENTIG) is a mu opioid receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
FDA: approved EMA: approved Alimentary tract and metabolism (A06) A06AH03
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — naloxegol
- US status
- approved
- Class
- Alimentary tract and metabolism (A06)
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
naloxegol (MOVENTIG) is a mu opioid receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN naloxegol
Brand MOVENTIG
Mechanism Mu opioid receptor antagonist
Therapeutic class Alimentary tract and metabolism (A06)
Route ORAL
Formulation TABLET
ATC code A06AH03
Mechanism of action
Mu opioid receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is naloxegol?
naloxegol (MOVENTIG) is a mu opioid receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for naloxegol?
MOVENTIG is a marketed brand name for naloxegol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of naloxegol?
naloxegol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.